Group One Trading
VOR icon

Group One Trading’s Vor Biopharma VOR Stock Holding History

Group One Trading’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Sell
600
-50,900
-99% -$770K ﹤0.01% 6333
2026
Q1 		$919K Sell
51,500
-133,500
-72% -$1.88M ﹤0.01% 2805
2025
Q4 		$2.42M Sell
185,000
-1,876,900
-91% -$34.9M ﹤0.01% 2111
2025
Q3 		$100M Buy
2,061,900
+1,991,405
+2,825% +$80.1M 0.18% 91
2025
Q2 		$2.28M Buy
70,495
+68,545
+3,515% +$606K 0.01% 2006
2025
Q1 		$28K Sell
1,950
-520
-21% -$12.5K ﹤0.01% 5590
2024
Q4 		$54.8K Buy
2,470
+1,975
+399% +$32.7K ﹤0.01% 4983
2024
Q3 		$6.93K Sell
495
-210
-30% -$3.83K ﹤0.01% 5762
2024
Q2 		$14.1K Hold
705
– – ﹤0.01% 5446
2024
Q1 		$33.4K Buy
+705
New +$31K ﹤0.01% 5039
2023
Q4 		– Sell
-100
Closed -$4.24K – 8258
2023
Q3 		$4.24K Buy
+100
New +$5.42K ﹤0.01% 6779
2023
Q2 		– Sell
-55
Closed -$5.92K – 8262
2023
Q1 		$5.92K Sell
55
-90
-62% -$9.97K ﹤0.01% 6208
2022
Q4 		$19.3K Buy
+145
New +$14.3K ﹤0.01% 5622

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Group One Trading's VOR Position: Q2 2026 in Review

Group One Trading reduced its Vor Biopharma (VOR) stake by 67% in Q2 2026, selling an estimated $92.3K and leaving 2,963 shares worth $54.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5338.

Group One Trading first reported a position in VOR in Q4 2023 and has held it in 7 quarters since. The position peaked at $162K in Q1 2026. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Group One Trading held 2,963 shares of Vor Biopharma worth $54.5K as of Q2 2026.
  • Group One Trading sold 6,102 Vor Biopharma shares in Q2 2026, an estimated $92.3K.
  • Vor Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5338 holding.
  • Group One Trading first reported a position in Vor Biopharma in Q4 2023 and has held it in 7 quarters since.
  • Group One Trading's Vor Biopharma position peaked at $162K in Q1 2026.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.